A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
Apr 12, 2024
0
60
The vaginal microbiome is believed to protect women against Chlamydia trachomatis, the etiological agent of the most prevalent sexually transmitted infections (STIs) in developed countries. New research by the University ...
Aug 13, 2019
0
455
Closing a critical gap in knowledge, Harvard Medical School scientists have unraveled the immune cascade that fuels tissue damage and disease development in chlamydia infection—the most common sexually transmitted disease ...
Feb 13, 2018
0
41
Scientists at the Wellcome Trust Sanger Institute and their collaborators at the University of British Columbia have created an innovative technique for studying how chlamydia interacts with the human immune system.
Apr 25, 2017
0
88
Researchers have developed a new assay for rapid and sensitive detection of Chlamydia trachomatis, the most common sexually transmitted infection (STI) in humans. This procedure takes less than 20 minutes and can be easily ...
Dec 12, 2013
0
0
Monash Institute of Medical Research scientists have found a protein in the female reproductive tract that protects against sexually transmitted diseases (STIs) such as chlamydia and herpes simplex virus (HSV).
Feb 28, 2013
0
0
(Medical Xpress) -- Researchers at Duke University Medical Center used mice to learn why genital Chlamydia infection remains chronic in women. The findings have important implications for developing strategies to treat Chlamydia ...
Jun 23, 2011
0
0
Just one dose of the antibiotic doxycycline taken after sex halved the number of chlamydia and syphilis cases in San Francisco, promising new research shows.
Mar 5, 2024
0
0
An internship in summer 2018 under the auspices of UdeM's PREMIER program for excellence in medicine through introduction to research has culminated in the publication of an article in a scientific journal for undergraduate ...
Feb 4, 2022
0
121
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends chlamydia and gonorrhea screening for all sexually active women aged 24 years and younger and those aged 25 years and older at increased risk for infection. ...
Sep 14, 2021
0
4
